48 results about "Release pattern" patented technology

A hologram laminate allows traces of separation of the hologram to be clearly left on both the adherend and the hologram label and hence makes it possible to prevent reuse of the hologram and is excellent in graphical design function and suitable for certification purposes. A hologram label used for the fabrication of the hologram laminate is also provided. The hologram laminate has a colored layer, a release pattern, a transparent film, a hologram layer and a surface protective layer laminated on an adherend in the order mentioned. The hologram layer includes a volume hologram layer and a relief hologram layer having a transparent thin-film layer over the surface of the relief interference fringe pattern. The volume hologram layer and the relief hologram layer are superimposed so as to be switchable from one to another. The hologram laminate is separable between the adherend and the transparent film. When the hologram is separated, the colored layer is left on the adherend in a pattern corresponding to the release pattern. The hologram label has a release sheet in place of the adherend in the hologram laminate.

The present invention relates to a controlled-release niacin formulation. In particular, the present invention relates to a controlled-release niacin formulation, comprising niacin; hydroxypropyl methylcellulose; and a carboxyvinyl polymer, in which the carboxyvinyl polymer and hydroxypropyl methylcellulose are contained in a predetermined weight ratio, and to a preparation method thereof. The controlled-release niacin formulation according to the present invention maintains its matrix shape until completion of release, and maintains its release pattern without fluctuation for a desired time period, unlike a commercial formulation. In particular, since niacin formulations are used for long-term treatment of hyperlipidemia, the controlled-release niacin formulation of the present invention, capable of maintaining effective blood concentration and high stability for a long period of time, is very useful.

The invention provides a hypnotic double-layer controlled release tablet, comprising a rapid-release layer and a slow-release layer, wherein the rapid-release layer is provided with pores which are filled with rapid-release particles; the rapid-release layer and the rapid-release particles are composed of hypnotic drug and pharmaceutical excipients; the slow-release layer is composed of a hypnotic drug, a slow-release material and pharmaceutical excipients. The hypnotic double-layer controlled release tablet has the following technical effects that 1) the physical stability of the double-layer tablet provided by the invention is better than that of the common double-layer table, which is advantageous for storage and transportation, and 2) a dissolution test detects that the disintegration time limit of the rapid-release layer of the double-layer tablet provided by the invention ranges from 20 seconds to 30 seconds; and the slow-release layer is in a zero-order release pattern, and therefore the effectiveness and safety of medication for a patient are greatly improved. In the preparation process of the double-layer tablet, the rapid-release particles fill in the pores. The drug release pattern of combined rapid release and slow release guarantees that the rapid-release layer is disintegrated rapidly after the drug is taken; as a result, the blood concentration is capable of quickly reaching the therapeutic window range; the slow-release layer is slowly released so that the therapeutic action is maintained for a long period of time and toxic and side effects are effectively controlled.

A device that delivers one or more substances into a vaginal lumen according to one of a plurality of release patterns. The device comprises a supporting structure, substance dispensers, and / or coupling elements which are configured to release one or more substances, for example, drugs, in manner designed to optimize treatment of one or more medical conditions.

An array substrate includes a metal pattern and an electrically conductive pattern formed sequentially on a base substrate. The electrically conductive pattern is insulated from the metal pattern; and a static charge releasing pattern is formed in a same layer as the electrically conductive pattern and formed by a same material as the electrically conductive pattern, the static charge releasing pattern being insulated from the electrically conductive pattern and electrically connected with the metal pattern.

An intrauterine device having at least one first pharmaceutically active ingredient and at least one first layer made of at least a first polymeric material, wherein between about 10 and about 60 v / v % of at least one particulate material is dispersed and / or incorporated in the first polymeric material. The presence of the particulate material will reduce the porosity of the polymer or otherwise obstruct the diffusion of the pharmaceutically active ingredient being released, thereby slowing its rate of release. In this way, it is possible to regulate the release rate and / or initial burst of the device, simply by adjusting the amount of particles / particulate material in the first layer, instead of having to adapt the size of the device to the desired release pattern, which requires expensive changes in production equipment and manufacturing processes.

The present invention relates to a complex containing celecoxib and tramadol. The present invention is designed such that, even though two different active ingredients are prepared into a single dosage form, the release patterns of respective drugs are optimized in the expression of synergy effects, with respect to pain, of the respective drugs, through the new prescription.